Solasto Corporation (JPX: 6197.T) Stock Competitors & Peer Comparison
See 6197.T's competitors and their performance on the JPX and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for 6197.T and its JPX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 6197.T | ¥1,118.00 | +0.54% | 101.2B | 27.39 | ¥40.82 | +1.97% |
| 6062.T | ¥1,433.00 | -1.38% | 46.8B | 10.90 | ¥131.49 | +3.00% |
| 6099.T | ¥734.00 | -1.34% | 44.4B | 14.14 | ¥51.90 | +2.04% |
| 7071.T | ¥393.00 | -1.26% | 38.6B | 12.21 | ¥32.19 | +1.02% |
| 2372.T | ¥2,790.00 | +0.00% | 33.8B | 131.60 | ¥21.20 | N/A |
| 2374.T | ¥1,212.00 | +0.00% | 29.9B | 0.00 | ¥413,067,936.00 | +2.48% |
| 286A.T | ¥770.00 | -3.02% | 27.6B | 10.03 | ¥76.75 | N/A |
| 9158.T | ¥800.00 | -0.25% | 23.5B | 9.92 | ¥80.66 | N/A |
| 7634.T | ¥5,250.00 | +2.14% | 16.4B | 11.94 | ¥439.59 | +1.71% |
| 194A.T | ¥1,694.00 | -2.42% | 12.8B | 29.49 | ¥57.44 | N/A |
Stock Comparison
Charm Care Corporation (JPX: 6062.T)
6197.T vs 6062.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 6062.T has a market cap of 46.8B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 6062.T trades at ¥1,433.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 6062.T's P/E ratio is 10.90. In terms of profitability, 6197.T's ROE is +0.16%, compared to 6062.T's ROE of +0.19%. Regarding short-term risk, 6197.T is less volatile compared to 6062.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 6062.T's competition here
Elan Corporation (JPX: 6099.T)
6197.T vs 6099.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 6099.T has a market cap of 44.4B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 6099.T trades at ¥734.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 6099.T's P/E ratio is 14.14. In terms of profitability, 6197.T's ROE is +0.16%, compared to 6099.T's ROE of +0.22%. Regarding short-term risk, 6197.T is less volatile compared to 6099.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 6099.T's competition here
Amvis Holdings, Inc. (JPX: 7071.T)
6197.T vs 7071.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 7071.T has a market cap of 38.6B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 7071.T trades at ¥393.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 7071.T's P/E ratio is 12.21. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7071.T's ROE of +0.08%. Regarding short-term risk, 6197.T is less volatile compared to 7071.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7071.T's competition here
I'rom Group Co., Ltd. (JPX: 2372.T)
6197.T vs 2372.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 2372.T has a market cap of 33.8B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 2372.T trades at ¥2,790.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 2372.T's P/E ratio is 131.60. In terms of profitability, 6197.T's ROE is +0.16%, compared to 2372.T's ROE of +0.11%. Regarding short-term risk, 6197.T is more volatile compared to 2372.T. This indicates higher risk in terms of short-term price fluctuations for 6197.T.Check 2372.T's competition here
Saint-Care Holding Corporation (JPX: 2374.T)
6197.T vs 2374.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 2374.T has a market cap of 29.9B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 2374.T trades at ¥1,212.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 2374.T's P/E ratio is 0.00. In terms of profitability, 6197.T's ROE is +0.16%, compared to 2374.T's ROE of +0.10%. Regarding short-term risk, 6197.T is more volatile compared to 2374.T. This indicates higher risk in terms of short-term price fluctuations for 6197.T.Check 2374.T's competition here
EUCALIA, Inc. (JPX: 286A.T)
6197.T vs 286A.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 286A.T has a market cap of 27.6B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 286A.T trades at ¥770.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 286A.T's P/E ratio is 10.03. In terms of profitability, 6197.T's ROE is +0.16%, compared to 286A.T's ROE of N/A. Regarding short-term risk, 6197.T is less volatile compared to 286A.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 286A.T's competition here
CUC Inc. (JPX: 9158.T)
6197.T vs 9158.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 9158.T has a market cap of 23.5B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 9158.T trades at ¥800.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 9158.T's P/E ratio is 9.92. In terms of profitability, 6197.T's ROE is +0.16%, compared to 9158.T's ROE of +0.07%. Regarding short-term risk, 6197.T is less volatile compared to 9158.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 9158.T's competition here
Hoshi Iryo-Sanki Co., Ltd. (JPX: 7634.T)
6197.T vs 7634.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 7634.T has a market cap of 16.4B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 7634.T trades at ¥5,250.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 7634.T's P/E ratio is 11.94. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7634.T's ROE of +0.07%. Regarding short-term risk, 6197.T is less volatile compared to 7634.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7634.T's competition here
WOLVES HAND Co., Ltd. (JPX: 194A.T)
6197.T vs 194A.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 194A.T has a market cap of 12.8B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 194A.T trades at ¥1,694.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 194A.T's P/E ratio is 29.49. In terms of profitability, 6197.T's ROE is +0.16%, compared to 194A.T's ROE of +0.29%. Regarding short-term risk, 6197.T is less volatile compared to 194A.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 194A.T's competition here
HYUGA PRIMARY CARE Co.,Ltd. (JPX: 7133.T)
6197.T vs 7133.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 7133.T has a market cap of 9.5B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 7133.T trades at ¥1,330.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 7133.T's P/E ratio is 15.42. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7133.T's ROE of +0.24%. Regarding short-term risk, 6197.T is more volatile compared to 7133.T. This indicates higher risk in terms of short-term price fluctuations for 6197.T.Check 7133.T's competition here
Advantage Risk Management Co., Ltd. (JPX: 8769.T)
6197.T vs 8769.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 8769.T has a market cap of 8.4B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 8769.T trades at ¥535.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 8769.T's P/E ratio is 12.23. In terms of profitability, 6197.T's ROE is +0.16%, compared to 8769.T's ROE of +0.17%. Regarding short-term risk, 6197.T is less volatile compared to 8769.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 8769.T's competition here
QLS Holdings Co., Ltd. (JPX: 7075.T)
6197.T vs 7075.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 7075.T has a market cap of 7.4B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 7075.T trades at ¥993.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 7075.T's P/E ratio is 12.90. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7075.T's ROE of N/A. Regarding short-term risk, 6197.T is less volatile compared to 7075.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7075.T's competition here
UCHIYAMA HOLDINGS Co.,Ltd. (JPX: 6059.T)
6197.T vs 6059.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 6059.T has a market cap of 7.3B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 6059.T trades at ¥374.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 6059.T's P/E ratio is 6.69. In terms of profitability, 6197.T's ROE is +0.16%, compared to 6059.T's ROE of +0.07%. Regarding short-term risk, 6197.T is less volatile compared to 6059.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 6059.T's competition here
AS Partners Co. Ltd. (JPX: 160A.T)
6197.T vs 160A.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 160A.T has a market cap of 7B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 160A.T trades at ¥1,963.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 160A.T's P/E ratio is 16.66. In terms of profitability, 6197.T's ROE is +0.16%, compared to 160A.T's ROE of +0.08%. Regarding short-term risk, 6197.T is less volatile compared to 160A.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 160A.T's competition here
Care Twentyone Corporation (JPX: 2373.T)
6197.T vs 2373.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 2373.T has a market cap of 6B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 2373.T trades at ¥446.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 2373.T's P/E ratio is 21.55. In terms of profitability, 6197.T's ROE is +0.16%, compared to 2373.T's ROE of +0.07%. Regarding short-term risk, 6197.T is less volatile compared to 2373.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 2373.T's competition here
Living Platform,Ltd. (JPX: 7091.T)
6197.T vs 7091.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 7091.T has a market cap of 5.8B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 7091.T trades at ¥1,300.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 7091.T's P/E ratio is 12.08. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7091.T's ROE of +0.20%. Regarding short-term risk, 6197.T is less volatile compared to 7091.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7091.T's competition here
Hi-CRATES CO.,LTD. (JPX: 4172.T)
6197.T vs 4172.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 4172.T has a market cap of 5.2B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 4172.T trades at ¥2,326.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 4172.T's P/E ratio is 9.99. In terms of profitability, 6197.T's ROE is +0.16%, compared to 4172.T's ROE of +0.12%. Regarding short-term risk, 6197.T is more volatile compared to 4172.T. This indicates higher risk in terms of short-term price fluctuations for 6197.T.Check 4172.T's competition here
AIAI Group Corporation (JPX: 6557.T)
6197.T vs 6557.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 6557.T has a market cap of 4.6B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 6557.T trades at ¥712.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 6557.T's P/E ratio is 6.95. In terms of profitability, 6197.T's ROE is +0.16%, compared to 6557.T's ROE of +0.21%. Regarding short-term risk, 6197.T is less volatile compared to 6557.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 6557.T's competition here
Japan Hospice Holdings Inc. (JPX: 7061.T)
6197.T vs 7061.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 7061.T has a market cap of 4.2B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 7061.T trades at ¥495.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 7061.T's P/E ratio is 12.67. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7061.T's ROE of +0.09%. Regarding short-term risk, 6197.T is less volatile compared to 7061.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7061.T's competition here
Sunwels Co.,Ltd. (JPX: 9229.T)
6197.T vs 9229.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 9229.T has a market cap of 3.7B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 9229.T trades at ¥113.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 9229.T's P/E ratio is -2.46. In terms of profitability, 6197.T's ROE is +0.16%, compared to 9229.T's ROE of -0.22%. Regarding short-term risk, 6197.T is less volatile compared to 9229.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 9229.T's competition here
teno. Holdings Company Limited (JPX: 7037.T)
6197.T vs 7037.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 7037.T has a market cap of 3.6B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 7037.T trades at ¥795.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 7037.T's P/E ratio is 28.21. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7037.T's ROE of +0.07%. Regarding short-term risk, 6197.T is less volatile compared to 7037.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7037.T's competition here
FB Care Service Co.,Ltd. (JPX: 9220.T)
6197.T vs 9220.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 9220.T has a market cap of 3.1B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 9220.T trades at ¥1,259.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 9220.T's P/E ratio is 6.91. In terms of profitability, 6197.T's ROE is +0.16%, compared to 9220.T's ROE of +0.11%. Regarding short-term risk, 6197.T is more volatile compared to 9220.T. This indicates higher risk in terms of short-term price fluctuations for 6197.T.Check 9220.T's competition here
Emergency Assistance Japan Co., Ltd. (JPX: 6063.T)
6197.T vs 6063.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 6063.T has a market cap of 2.5B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 6063.T trades at ¥1,008.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 6063.T's P/E ratio is 18.72. In terms of profitability, 6197.T's ROE is +0.16%, compared to 6063.T's ROE of +0.07%. Regarding short-term risk, 6197.T is less volatile compared to 6063.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 6063.T's competition here
Care Service Co.,Ltd. (JPX: 2425.T)
6197.T vs 2425.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 2425.T has a market cap of 2.5B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 2425.T trades at ¥663.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 2425.T's P/E ratio is 29.81. In terms of profitability, 6197.T's ROE is +0.16%, compared to 2425.T's ROE of +0.03%. Regarding short-term risk, 6197.T is more volatile compared to 2425.T. This indicates higher risk in terms of short-term price fluctuations for 6197.T.Check 2425.T's competition here
D&m Co. Co. Ltd. (JPX: 189A.T)
6197.T vs 189A.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 189A.T has a market cap of 2.5B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 189A.T trades at ¥1,083.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 189A.T's P/E ratio is 11.16. In terms of profitability, 6197.T's ROE is +0.16%, compared to 189A.T's ROE of +0.10%. Regarding short-term risk, 6197.T is less volatile compared to 189A.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 189A.T's competition here
AHC Group Inc. (JPX: 7083.T)
6197.T vs 7083.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 7083.T has a market cap of 2.4B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 7083.T trades at ¥1,170.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 7083.T's P/E ratio is 289.60. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7083.T's ROE of +0.01%. Regarding short-term risk, 6197.T is less volatile compared to 7083.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7083.T's competition here
CEDAR.Co.,Ltd. (JPX: 2435.T)
6197.T vs 2435.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 2435.T has a market cap of 2.3B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 2435.T trades at ¥206.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 2435.T's P/E ratio is 4.79. In terms of profitability, 6197.T's ROE is +0.16%, compared to 2435.T's ROE of +0.26%. Regarding short-term risk, 6197.T is less volatile compared to 2435.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 2435.T's competition here
Artra Group Corporation (JPX: 6029.T)
6197.T vs 6029.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 6029.T has a market cap of 1.9B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 6029.T trades at ¥189.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 6029.T's P/E ratio is 20.06. In terms of profitability, 6197.T's ROE is +0.16%, compared to 6029.T's ROE of +0.06%. Regarding short-term risk, 6197.T is less volatile compared to 6029.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 6029.T's competition here
Fureasu Co.,Ltd. (JPX: 7062.T)
6197.T vs 7062.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 7062.T has a market cap of 1.8B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 7062.T trades at ¥681.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 7062.T's P/E ratio is 2.92. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7062.T's ROE of +0.29%. Regarding short-term risk, 6197.T is less volatile compared to 7062.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7062.T's competition here
Recovery International Co.,Ltd. (JPX: 9214.T)
6197.T vs 9214.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 9214.T has a market cap of 1.7B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 9214.T trades at ¥1,294.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 9214.T's P/E ratio is 15.75. In terms of profitability, 6197.T's ROE is +0.16%, compared to 9214.T's ROE of +0.15%. Regarding short-term risk, 6197.T is more volatile compared to 9214.T. This indicates higher risk in terms of short-term price fluctuations for 6197.T.Check 9214.T's competition here
Ligua Inc. (JPX: 7090.T)
6197.T vs 7090.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 7090.T has a market cap of 1.6B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 7090.T trades at ¥985.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 7090.T's P/E ratio is -8.12. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7090.T's ROE of -1.00%. Regarding short-term risk, 6197.T is less volatile compared to 7090.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7090.T's competition here
Terminalcare Support Institute Inc. (JPX: 7362.T)
6197.T vs 7362.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 7362.T has a market cap of 1.4B. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 7362.T trades at ¥890.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 7362.T's P/E ratio is 9.34. In terms of profitability, 6197.T's ROE is +0.16%, compared to 7362.T's ROE of +0.10%. Regarding short-term risk, 6197.T is less volatile compared to 7362.T. This indicates lower risk in terms of short-term price fluctuations for 6197.T.Check 7362.T's competition here
HUMAN ADJUST Co.,Ltd. (JPX: 249A.T)
6197.T vs 249A.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 249A.T has a market cap of 510M. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 249A.T trades at ¥1,700.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 249A.T's P/E ratio is 18.32. In terms of profitability, 6197.T's ROE is +0.16%, compared to 249A.T's ROE of N/A. Regarding short-term risk, 6197.T is more volatile compared to 249A.T. This indicates higher risk in terms of short-term price fluctuations for 6197.T.Check 249A.T's competition here
Magonote Inc. (JPX: 514A.T)
6197.T vs 514A.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 514A.T has a market cap of 469M. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 514A.T trades at ¥469.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 514A.T's P/E ratio is 3.36. In terms of profitability, 6197.T's ROE is +0.16%, compared to 514A.T's ROE of N/A. Regarding short-term risk, 6197.T is more volatile compared to 514A.T. This indicates higher risk in terms of short-term price fluctuations for 6197.T.Check 514A.T's competition here
Genkinakaigo Co. Ltd. (JPX: 599A.T)
6197.T vs 599A.T Comparison September 2026
Solasto Corporation (JPX: 6197.T) plays a significant role within the Healthcare sector. Its performance on the JPX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6197.T stands at 101.2B. In comparison, 599A.T has a market cap of 0. Regarding current trading prices, 6197.T is priced at ¥1,118.00 on the JPX, while 599A.T trades at ¥300.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6197.T currently has a P/E ratio of 27.39, whereas 599A.T's P/E ratio is 12.79. In terms of profitability, 6197.T's ROE is +0.16%, compared to 599A.T's ROE of N/A. Regarding short-term risk, 6197.T is more volatile compared to 599A.T. This indicates higher risk in terms of short-term price fluctuations for 6197.T.Check 599A.T's competition here